{
    "nct_id": "NCT03734601",
    "official_title": "Very Low-dose Total Body Irradiation in Combination With Total Lymphoid Irradiation and Anti-Thymocyte Globulin to Improve Donor Engraftment in Patients Undergoing Non-Myeloablative Hematopoietic Cell Transplantation",
    "inclusion_criteria": "INCLUSION CRITERIA\n\n* Has a human leukocyte antigen (HLA)-matched or single allele mismatched adult sibling donor or unrelated donor.\n* Acute myeloid leukemia (AML); myelodysplastic syndrome (MDS); myeloproliferative disease syndrome (MPD)]; chronic lymphocytic leukemia (CLL); B- or T-cell non Hodgkin lymphoma (NHL); Hodgkin lymphoma (HL); or chronic myelomonocytic leukemia (CMML), suitable for treatment with allogeneic transplant after TLI and ATG reduced intensity conditioning.\n* Considered at high-risk for regimen-related toxicity from fully-ablative transplant conditioning (therefore reduced-intensity conditioning is recommended).\n* Ability to understand and the willingness to sign a written informed consent document. Patients must have signed informed consent to participate in the trial.\n\nEXCLUSION CRITERIA\n\n* Uncontrolled bacterial, viral or fungal infection defined as currently taking medication and progression of clinical symptoms.\n* Progressive hemato lymphoid malignancy despite conventional therapy.\n* Chronic myelogenous leukemia (CML).\n* Active CNS involvement of the underlying malignancy.\n* HIV positive\n* Pregnant or lactating\n* Prior malignancy (EXCEPTION: diagnosed > 5 years ago without evidence of disease, OR treated ≤ 5 years ago but have a greater than 50% chance of life expectancy of ≥ 5 years for that malignancy).\n* Have a psychiatric disorder(s) or psychosocial circumstance(s) which in the opinion of the primary physician would place the patient at an unacceptable risk from transplant.\n* Left ventricular ejection fraction (LEVF) < 30%, or uncontrolled cardiac failure\n* Diffusing capacity of lung for carbon monoxide (DLCO) < 40% predicted\n* Total bilirubin > 3 mg/dL\n* Serum glutamic oxaloacetic transaminase (SGOT) or serum glutamic-pyruvic transaminase (SGPT) > 4 x upper limit of normal (ULN)\n* Creatinine > 2 mg/dL and an estimated creatinine clearance < 40 mL/min\n* Poorly-controlled hypertension despite multiple antihypertensive medications\n* Karnofsky Performance Status (KPS) < 60%\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}